NM_145261.4(DNAJC19):c.69G>A (p.Leu23=) AND not specified

Germline classification:: Benign (2 submissions)
Last evaluated:: Sep 11, 2017
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000124749.2

Allele description [Variation Report for NM_145261.4(DNAJC19):c.69G>A (p.Leu23=)]

NM_145261.4(DNAJC19):c.69G>A (p.Leu23=)

Gene:

DNAJC19:DnaJ heat shock protein family (Hsp40) member C19 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

3q26.33

Genomic location:

Preferred name:

NM_145261.4(DNAJC19):c.69G>A (p.Leu23=)

Other names:

p.L23L:TTG>TTA

HGVS:

NC_000003.12:g.180988083C>T
NG_022933.1:g.6692G>A
NM_001190233.2:c.-7G>A
NM_145261.4:c.69G>AMANE SELECT
NP_660304.1:p.Leu23=
LRG_743t1:c.69G>A
LRG_743:g.6692G>A
LRG_743p1:p.Leu23=
NC_000003.11:g.180705871C>T
NM_145261.3:c.69G>A
NR_033721.2:n.151G>A
NR_033722.2:n.203G>A
NR_033723.1:n.241G>A

Links:

dbSNP: rs142023670

NCBI 1000 Genomes Browser:

rs142023670

Molecular consequence:

NM_001190233.2:c.-7G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NR_033721.2:n.151G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_033722.2:n.203G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_033723.1:n.241G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NM_145261.4:c.69G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000168188	GeneDx	criteria provided, single submitter (GeneDx Variant Classification (06012015))	Benign (Feb 21, 2014)	germline	clinical testing	Citation Link,
SCV000917298	Women's Health and Genetics/Laboratory Corporation of America, LabCorp	criteria provided, single submitter (LabCorp Variant Classification Summary - May 2015)	Benign (Sep 11, 2017)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000168188

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification (06012015))

Benign
(Feb 21, 2014)

germline

clinical testing

Citation Link,

SCV000917298

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)

Benign
(Sep 11, 2017)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From GeneDx, SCV000168188.12

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000917298.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

Variant summary: The c.69G>A (p.Leu23=) in DNAJC19 gene is a synonymous change that involves a mildly conserved nucleotide. 5/5 programs in Alamut predict that this variant does not affect splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in control dataset of ExAC at a frequency of 0.0044 (540/ 121392 chrs tested, including 4 homozygotes). These frequencies exceed the estimated maximum allele frequency for a pathogenic allele in this gene (0.000025). The variant of interest has not, to our knowledge, been reported in affected individuals via published reports, but is sited as Benign by a reputable database/clinical laboratory. Taking together, the variant was classified as Benign.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Jul 13, 2025

ClinVar

Relating variation to medicine